Fortress Biotech, Inc.FBIONASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank60
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-62.23%
↑ 72% vs avg
Percentile
P60
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-219.98%
Historical baseline
PeriodValueYoY Change
TTM-62.23%+65.7%
2024-181.17%-12.8%
2023-160.59%+37.2%
2022-255.73%-20.4%
2021-212.48%-10.3%
2020-192.59%+20.3%
2019-241.55%+45.2%
2018-440.45%-832.9%
2017-47.21%+88.4%
2016-405.77%-